Survival benefit of hepatic resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis
Abstract Background No consensus treatment has been reached for hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT). Hepatic resection (HR) and transarterial chemoembolization (TACE) have been recommended as effective options, but which is better remains unclear. This meta-analysis...
Autores principales: | Xiu-Ping Zhang, Kang Wang, Nan Li, Cheng-Qian Zhong, Xu-Biao Wei, Yu-Qiang Cheng, Yu-Zhen Gao, Han Wang, Shu-Qun Cheng |
---|---|
Formato: | Artículo |
Lenguaje: | English |
Publicado: |
BMC
2017-12-01
|
Colección: | BMC Cancer |
Materias: | |
Acceso en línea: | http://link.springer.com/article/10.1186/s12885-017-3895-z |
Ejemplares similares
-
Transarterial chemoembolization for hepatocellular carcinoma combined with portal vein tumor thrombosis
por: Lv WF, et al.
Publicado: (2018-10-01) -
Prognosis of patients with hepatocellular carcinoma and portal vein tumor thrombus treated with combination of transarterial chemoembolization and palliative thermal ablation
por: Qunfang Zhou, et al.
Publicado: (2022-12-01) -
Safety, efficacy, and survival of drug-eluting beads-transarterial chemoembolization vs. conventional-transarterial chemoembolization in advanced HCC patients with main portal vein tumor thrombus
por: Junwei Chen, et al.
Publicado: (2023-07-01) -
Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis
por: Jung Min Lee, et al.
Publicado: (2016-03-01) -
Immune-Targeted Therapy with or without Transarterial Chemoembolization (TACE) for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis (PVTT): A Multicenter Retrospective Study
por: Ran You, et al.
Publicado: (2024-09-01)